ARCHIVES

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

Letter: The Lesson From Dana-Farber

July 28, 1995

NCAB Supports NCI Director’s Call For Increase In Management Funds.

December 8, 2000

Congressional News: Senate Subcommittee Recommends $2.3 Bil. Budget for NCI

September 13, 1996

Non-Adherence To Protocol Explains Outcome Differences In Hispanic Children With ALL

December 31, 2010

Gallo Actively Searching For New Position

July 1, 1994

Cancel Panel Activity Ceases Due To Hammer’s Death; Oxy Chairman Promoted Funding Of Research

January 4, 1991